Report cover image

Cyanocobalamin API Industry Research Report 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 124 Pages
SKU # APRC20352994

Description

Summary

According to APO Research, the global Cyanocobalamin API market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Cyanocobalamin API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Cyanocobalamin API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Cyanocobalamin API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Cyanocobalamin API include Sanofi, Kingvit, North China Pharmaceutical Group, Hebei Yuxing Bio-Engineering, Hebei Huarong Pharmaceutical, GlaxoSmithKline, Wockhardt, Rochem International and EuroAPI, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cyanocobalamin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyanocobalamin API.

The report will help the Cyanocobalamin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Cyanocobalamin API market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cyanocobalamin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Cyanocobalamin API Segment by Company

Sanofi
Kingvit
North China Pharmaceutical Group
Hebei Yuxing Bio-Engineering
Hebei Huarong Pharmaceutical
GlaxoSmithKline
Wockhardt
Rochem International
EuroAPI
Bristol Myers Squibb
Basic Nutrition
Antibiotice
Cyanocobalamin API Segment by Type

Crystal
Powder
Cyanocobalamin API Segment by Application

Contract Manufacturing Organizations
Pharmaceutical Companies
Others
Cyanocobalamin API Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyanocobalamin API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cyanocobalamin API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyanocobalamin API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cyanocobalamin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cyanocobalamin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cyanocobalamin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Table of Contents

124 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Cyanocobalamin API Market Size (2020-2031)
2.2.2 Global Cyanocobalamin API Sales (2020-2031)
2.2.3 Global Cyanocobalamin API Market Average Price (2020-2031)
2.3 Cyanocobalamin API by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Crystal
2.3.3 Powder
2.4 Cyanocobalamin API by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Contract Manufacturing Organizations
2.4.3 Pharmaceutical Companies
2.4.4 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Cyanocobalamin API Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Cyanocobalamin API Sales (K Units) of Manufacturers (2020-2025)
3.3 Global Cyanocobalamin API Revenue of Manufacturers (2020-2025)
3.4 Global Cyanocobalamin API Average Price by Manufacturers (2020-2025)
3.5 Global Cyanocobalamin API Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Cyanocobalamin API, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Cyanocobalamin API, Product Type & Application
3.8 Global Manufacturers of Cyanocobalamin API, Established Date
3.9 Global Cyanocobalamin API Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Sanofi
4.1.1 Sanofi Company Information
4.1.2 Sanofi Business Overview
4.1.3 Sanofi Cyanocobalamin API Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Sanofi Cyanocobalamin API Product Portfolio
4.1.5 Sanofi Recent Developments
4.2 Kingvit
4.2.1 Kingvit Company Information
4.2.2 Kingvit Business Overview
4.2.3 Kingvit Cyanocobalamin API Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Kingvit Cyanocobalamin API Product Portfolio
4.2.5 Kingvit Recent Developments
4.3 North China Pharmaceutical Group
4.3.1 North China Pharmaceutical Group Company Information
4.3.2 North China Pharmaceutical Group Business Overview
4.3.3 North China Pharmaceutical Group Cyanocobalamin API Sales, Revenue and Gross Margin (2020-2025)
4.3.4 North China Pharmaceutical Group Cyanocobalamin API Product Portfolio
4.3.5 North China Pharmaceutical Group Recent Developments
4.4 Hebei Yuxing Bio-Engineering
4.4.1 Hebei Yuxing Bio-Engineering Company Information
4.4.2 Hebei Yuxing Bio-Engineering Business Overview
4.4.3 Hebei Yuxing Bio-Engineering Cyanocobalamin API Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Hebei Yuxing Bio-Engineering Cyanocobalamin API Product Portfolio
4.4.5 Hebei Yuxing Bio-Engineering Recent Developments
4.5 Hebei Huarong Pharmaceutical
4.5.1 Hebei Huarong Pharmaceutical Company Information
4.5.2 Hebei Huarong Pharmaceutical Business Overview
4.5.3 Hebei Huarong Pharmaceutical Cyanocobalamin API Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Hebei Huarong Pharmaceutical Cyanocobalamin API Product Portfolio
4.5.5 Hebei Huarong Pharmaceutical Recent Developments
4.6 GlaxoSmithKline
4.6.1 GlaxoSmithKline Company Information
4.6.2 GlaxoSmithKline Business Overview
4.6.3 GlaxoSmithKline Cyanocobalamin API Sales, Revenue and Gross Margin (2020-2025)
4.6.4 GlaxoSmithKline Cyanocobalamin API Product Portfolio
4.6.5 GlaxoSmithKline Recent Developments
4.7 Wockhardt
4.7.1 Wockhardt Company Information
4.7.2 Wockhardt Business Overview
4.7.3 Wockhardt Cyanocobalamin API Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Wockhardt Cyanocobalamin API Product Portfolio
4.7.5 Wockhardt Recent Developments
4.8 Rochem International
4.8.1 Rochem International Company Information
4.8.2 Rochem International Business Overview
4.8.3 Rochem International Cyanocobalamin API Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Rochem International Cyanocobalamin API Product Portfolio
4.8.5 Rochem International Recent Developments
4.9 EuroAPI
4.9.1 EuroAPI Company Information
4.9.2 EuroAPI Business Overview
4.9.3 EuroAPI Cyanocobalamin API Sales, Revenue and Gross Margin (2020-2025)
4.9.4 EuroAPI Cyanocobalamin API Product Portfolio
4.9.5 EuroAPI Recent Developments
4.10 Bristol Myers Squibb
4.10.1 Bristol Myers Squibb Company Information
4.10.2 Bristol Myers Squibb Business Overview
4.10.3 Bristol Myers Squibb Cyanocobalamin API Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Bristol Myers Squibb Cyanocobalamin API Product Portfolio
4.10.5 Bristol Myers Squibb Recent Developments
4.11 Basic Nutrition
4.11.1 Basic Nutrition Company Information
4.11.2 Basic Nutrition Business Overview
4.11.3 Basic Nutrition Cyanocobalamin API Sales, Revenue and Gross Margin (2020-2025)
4.11.4 Basic Nutrition Cyanocobalamin API Product Portfolio
4.11.5 Basic Nutrition Recent Developments
4.12 Antibiotice
4.12.1 Antibiotice Company Information
4.12.2 Antibiotice Business Overview
4.12.3 Antibiotice Cyanocobalamin API Sales, Revenue and Gross Margin (2020-2025)
4.12.4 Antibiotice Cyanocobalamin API Product Portfolio
4.12.5 Antibiotice Recent Developments
5 Global Cyanocobalamin API Market Scenario by Region
5.1 Global Cyanocobalamin API Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Cyanocobalamin API Sales by Region: 2020-2031
5.2.1 Global Cyanocobalamin API Sales by Region: 2020-2025
5.2.2 Global Cyanocobalamin API Sales by Region: 2026-2031
5.3 Global Cyanocobalamin API Revenue by Region: 2020-2031
5.3.1 Global Cyanocobalamin API Revenue by Region: 2020-2025
5.3.2 Global Cyanocobalamin API Revenue by Region: 2026-2031
5.4 North America Cyanocobalamin API Market Facts & Figures by Country
5.4.1 North America Cyanocobalamin API Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Cyanocobalamin API Sales by Country (2020-2031)
5.4.3 North America Cyanocobalamin API Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.5 Europe Cyanocobalamin API Market Facts & Figures by Country
5.5.1 Europe Cyanocobalamin API Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Cyanocobalamin API Sales by Country (2020-2031)
5.5.3 Europe Cyanocobalamin API Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.5.9 Nordic Countries
5.6 Asia Pacific Cyanocobalamin API Market Facts & Figures by Country
5.6.1 Asia Pacific Cyanocobalamin API Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Cyanocobalamin API Sales by Country (2020-2031)
5.6.3 Asia Pacific Cyanocobalamin API Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Cyanocobalamin API Market Facts & Figures by Country
5.7.1 South America Cyanocobalamin API Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Cyanocobalamin API Sales by Country (2020-2031)
5.7.3 South America Cyanocobalamin API Revenue by Country (2020-2031)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Cyanocobalamin API Market Facts & Figures by Country
5.8.1 Middle East and Africa Cyanocobalamin API Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Cyanocobalamin API Sales by Country (2020-2031)
5.8.3 Middle East and Africa Cyanocobalamin API Revenue by Country (2020-2031)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Cyanocobalamin API Sales by Type (2020-2031)
6.1.1 Global Cyanocobalamin API Sales by Type (2020-2031) & (K Units)
6.1.2 Global Cyanocobalamin API Sales Market Share by Type (2020-2031)
6.2 Global Cyanocobalamin API Revenue by Type (2020-2031)
6.2.1 Global Cyanocobalamin API Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Cyanocobalamin API Revenue Market Share by Type (2020-2031)
6.3 Global Cyanocobalamin API Price by Type (2020-2031)
7 Segment by Application
7.1 Global Cyanocobalamin API Sales by Application (2020-2031)
7.1.1 Global Cyanocobalamin API Sales by Application (2020-2031) & (K Units)
7.1.2 Global Cyanocobalamin API Sales Market Share by Application (2020-2031)
7.2 Global Cyanocobalamin API Revenue by Application (2020-2031)
7.2.1 Global Cyanocobalamin API Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Cyanocobalamin API Revenue Market Share by Application (2020-2031)
7.3 Global Cyanocobalamin API Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Cyanocobalamin API Value Chain Analysis
8.1.1 Cyanocobalamin API Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Cyanocobalamin API Production Mode & Process
8.2 Cyanocobalamin API Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Cyanocobalamin API Distributors
8.2.3 Cyanocobalamin API Customers
9 Global Cyanocobalamin API Analyzing Market Dynamics
9.1 Cyanocobalamin API Industry Trends
9.2 Cyanocobalamin API Industry Drivers
9.3 Cyanocobalamin API Industry Opportunities and Challenges
9.4 Cyanocobalamin API Industry Restraints
10 Report Conclusion
11 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.